(Press-News.org) Research at the Keck School of Medicine of the University of Southern California's (USC) Zilkha Neurogenetic Institute shows for the first time that the human placenta plays an active role in synthesizing serotonin, paving the way to new treatment strategies that could mitigate health impacts such as cardiovascular disease and mental illness.
The groundbreaking findings, conducted with researchers from Vanderbilt University as part of a Silvio Conte Center of Excellence grant from the National Institute of Mental Health, offer conclusive evidence that the placenta provides serotonin to the fetal forebrain, not through the mother's blood supply, as theorized for the past 60 years. The research, "A transient placental source of serotonin for the fetal forebrain," will be published in the journal Nature on April 21, 2011.
"Our research indicates that the placenta actually synthesizes serotonin, and the serotonin is released from the placenta into the fetal bloodstream where it can reach the fetal brain," said lead author Alexandre Bonnin, Ph.D. "The placenta was seen as a passive organ, but we now know that it has significant synthetic capabilities and has a much more critical role in developmental programming of the fetus than previously thought."
Bonnin's work with Pat Levitt, Ph.D., director of the Zilkha Neurogenetic Institute and corresponding author on the paper, included the invention of a unique technology known as a "placentometer" that monitors substances that pass through the mouse placenta from mother to fetus. This technology can incorporate genetic models of human disease, and could lead to targeted therapies that treat the mother without affecting the fetus, or vice versa.
"The findings by Dr. Bonnin and his collaborators open the door for future studies examining the potential role for targeted interventions in high-risk pregnancies where a perturbed intrauterine environment might negatively impact fetal brain development," said Istvan Seri, professor of pediatrics, Keck School, and director, Center for Fetal and Neonatal Medicine at Children's Hospital Los Angeles. "However, it will take many more basic, translational and clinical trials and many years until we can provide evidence that approaches like this one work."
Serotonin, a neurotransmitter known to affect wellbeing in humans, also has been implicated in brain, cardiac and pancreas development.
In the early stages of development, neurons that synthesize serotonin develop in the fetal hindbrain, where heart, respiration and other critical functions reside, eventually building their way up to the forebrain, the home of higher cognition and emotional regulation. The study shows that during this gap between hindbrain and forebrain serotonin development, the placenta is an important source of serotonin to the forebrain – a process that could be affected by the mother's nutrition, since her diet is the only source for the essential amino acid tryptophan.
"An altered capacity of the placenta to make and release serotonin could affect the levels of serotonin in the human forebrain as it does in the mouse," said Levitt. "Developmental programming of the fetal brain can set the stage for adult-onset health impacts including heart disease, diabetes and mental illness."
The research relates to a growing body of evidence that subtle, deleterious effects on the fetus as it develops could lead to a lifetime of chronic mental health problems, including anxiety disorders, learning and emotional disabilities and depression.
"Bonnin's research may be of particular importance for early onset brain disorders, such as autism, Asperger's syndrome and pediatric obsessive-compulsive disorder, where investigators are considering a role for serotonin based on human genetic studies," said Randy Blakely, Ph.D., director of the Vanderbilt Conte Center and a collaborator on the paper.
###
Alexandre Bonnin, Nick Goeden, Kevin Chen, Melissa L. Wilson, Jennifer King, Jean C. Shih, Randy D. Blakely, Evan S. Deneris, Pat Levitt. "A transient placental source of serotonin for the fetal forebrain." Nature, April 2011.
END
Researchers at the University of California, San Diego School of Medicine, the National Institutes of Health (NIH) and the Mayo Clinic have published promising results of a clinical study using an experimental anti-fibrotic and anti-inflammatory drug called pirfenidone to treat patients with diabetic nephropathy. Their study will be published in the April 21 issue of the Journal of the American Society of Nephrology (JASN).
Diabetic nephropathy remains the leading cause of end-stage kidney disease (ESKD) in the United States. It is a common complication of diabetes, ...
It has been more than a decade since Barcelona's Real Club de Golf El Prat hosted the Open de Espana.
The competition will make its triumphant return to the Catalan course on May 5th, with many of the top golfing professionals from the European Tour expected to star.
As well as the chance to boost their rankings, players are also competing for a prize pot of EUR2 million (GBP1.7 million).
The Open de Espana has previously been won by illustrious names such as Sergio Garcia, Padraig Harrington, Colin Montgomerie and Seve Ballesteros.
It is one of the oldest tournaments ...
New research identifies a distinctive population of immune cells that may play a key role in the pathogenesis of diabetes. The research, published by Cell Press and available online in the April 21st issue of Immunity, sheds new light on the pathogenesis of diabetes and may lead to the development of new more selective therapeutic strategies for diabetes and other autoimmune diseases of the accessory organs of the digestive system.
Type 1 diabetes (T1D) is a chronic autoimmune disease that develops when the immune system destroys insulin-producing cells in the pancreas. ...
Patients on peritoneal dialysis (PD) typically have a higher early survival rate than patients on hemodialysis (HD). New data suggest that this difference may be explained by a higher risk of early deaths among patients undergoing HD with central venous catheters, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
In a study that included more than 38,500 Canadian patients starting dialysis between 2001 and 2008, 63 percent started hemodialysis using a central catheter placed into one of the large veins. Seventeen ...
Madrid's Museo Nacional de Arte Reina Sofia is showing a collection of pictures from the worker-photography movement between 1926 and 1939.
A Hard Merciless Light will be on display until August 22nd 2011, displaying some fascinating examples of images used during that era in the press.
The installation explores how the partnership of photography and the leftist worker movement became intertwined and spread from humble beginnings in the Soviet Union to several other countries including the US and Spain.
In a statement, the organisers remarked: "The exhibition ...
LOS ALAMOS, New Mexico, April 22, 2011—Los Alamos National Laboratory scientists have developed a way to avoid the use of expensive platinum in hydrogen fuel cells, the environmentally friendly devices that might replace current power sources in everything from personal data devices to automobiles.
In a paper published today in Science, Los Alamos researchers Gang Wu, Christina Johnston, and Piotr Zelenay, joined by researcher Karren More of Oak Ridge National Laboratory, describe the use of a platinum-free catalyst in the cathode of a hydrogen fuel cell. Eliminating ...
LA JOLLA, CA—In stark contrast to normal cells, which only divide a finite number of times before they enter into a permanent state of growth arrest or simply die, cancer cells never cease to proliferate. Now, scientists at the Salk Institute for Biological Studies have uncovered an important clue to one of the mechanisms underlying cancer cell immortality.
Their findings, published in the April 22, 2011 issue of Molecular Cell, reveal an unanticipated structure at chromosome ends, which could be a key ingredient in the biological "elixir of life," potentially making ...
A major new exhibition called Rembrandt and the Face of Jesus opened at Paris's Louvre art space on Thursday (April 21st).
The installation will be on show until July 18th 2011 and sees world-famous masterpiece The Pilgrims at Emmaus take centre stage.
Rembrandt Harmenszoon van Rijn - best known by his first name - painted it in the 17th century.
The picture will form the centrepiece for an installation that explores the way Jesus was represented in his art, as well as in the paintings of his students.
Tickets for the exhibition cost EUR11 (GBP9.75), or visitors ...
New research reveals a strategy for disrupting the ability of bacteria to communicate and coordinate the expression of virulence factors. The study, published by Cell Press in the April 22nd issue of the journal Molecular Cell, may lead to the development of new antibacterial therapeutics.
Bacteria use a process called "quorum sensing" to synchronize group behaviors that promote pathogenesis. During the process of quorum sensing, bacteria communicate with one another via chemical signals called autoinducers. As the population increases, so do autoinducer concentrations. ...
Like You've Never Been Away is a heart-warming project for which a photographer has tracked down the people who appeared in his photographs of Granby and Everton in 1975.
Paul Trevor was sent to the areas to record inner city deprivation and produced a collection of images showing the defiant nature with which the communities faced their problems.
In a statement, he described how he found everyone to be full of humour and energy at the time and decided to revisit the project and update the public on what the participants had done with themselves after he left.
Mr ...
